Reporter Sept 13 2013
Kohl’s grant supports child passenger safety initiative at Children’s Hospital
Sep. 4, 2019— by Jessica Pasley Monroe Carell Jr. Children’s Hospital at Vanderbilt will allocate funding from a $120,000 grant from Kohl’s to support the child passenger safety initiative — Kohl’s Stay Seat Smart Program. The proposed Kohl’s Stay Seat Smart Program seeks to use a multipronged approach that addresses car seat misuse through education, community outreach...
Fishing for new anti-cancer drugs
Sep. 18, 2013—Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.
Mapping brain membrane proteins
Sep. 16, 2013—New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.
Cancer nanomedicines on target
Sep. 13, 2013—Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.
VU study identifies DNA changes in drug-resistant cancer cells
Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
Federal grant bolsters pulmonary fibrosis research
Sep. 12, 2013—Lisa Young, M.D., associate professor of Pediatrics and Medicine and Cell Biology, has been awarded a five-year, $1.9 million National Institutes of Health grant to study what causes cellular dysfunction and pulmonary fibrosis in patients with Hermansky-Pudlak syndrome (HPS).
New rounds series focuses on supporting caregivers
Sep. 12, 2013—Bedside Matters, a new hourlong, monthly rounds geared toward helping all Vanderbilt University Medical Center health care providers deal with the social and emotional issues of caring for patients and families, will begin this month.
VU tracking drug’s ability to prevent type 1 diabetes
Sep. 12, 2013—Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
Two named to National Academies’ advisory board
Sep. 12, 2013—Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism.
Discovery lecturer to discuss genetic information’s challenges
Sep. 12, 2013—Wylie Burke, M.D., Ph.D., an expert in the social, ethical and policy implications of genetic information, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 19.
Champ’s Corner Store open for business
Sep. 12, 2013—Building on an already successful venture to offer a variety of safety products to patients and families, the Monroe Carell Jr. Children’s Hospital at Vanderbilt has expanded its Safety Store to become Champ’s Corner Store.
Sleep education helps families of children with autism
Sep. 12, 2013—Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
